These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8285734)

  • 1. Over-the-counter clobetasol propionate.
    Otley CC; Sober A
    Arch Dermatol; 1994 Jan; 130(1):121. PubMed ID: 8285734
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous hypersensitivity to clobetasone butyrate and clobetasol propionate.
    Chalmers RJ; Beck MH; Muston HL
    Contact Dermatitis; 1983 Jul; 9(4):317-8. PubMed ID: 6225613
    [No Abstract]   [Full Text] [Related]  

  • 3. Unregulated use of clobetasol propionate.
    Keane FM; Munn SE; Taylor NF; du Vivier AW
    Br J Dermatol; 2001 May; 144(5):1095-6. PubMed ID: 11359411
    [No Abstract]   [Full Text] [Related]  

  • 4. Fragrances in topical over-the-counter medicaments - a loophole in EU legislation should be closed.
    Schliemann S; Geier J; Elsner P
    Contact Dermatitis; 2011 Dec; 65(6):367-8. PubMed ID: 22077440
    [No Abstract]   [Full Text] [Related]  

  • 5. Cushing's syndrome from topical glucocorticoids.
    Teelucksingh S; Bahall M; Coomansingh D; Suite M; Bartholomew C
    West Indian Med J; 1993 Jun; 42(2):77-8. PubMed ID: 8367969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact dermatitis from clobetasol propionate.
    Tosti A; Guerra L; Manuzzi P; Lama L
    Contact Dermatitis; 1987 Oct; 17(4):256-7. PubMed ID: 2962832
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study.
    Tzung TY; Liu YS; Chang HW
    Br J Dermatol; 2007 Jan; 156(1):191-2. PubMed ID: 17199600
    [No Abstract]   [Full Text] [Related]  

  • 8. Statinat-induced pemphigus: over-the-counter drugs too may be harmful!
    Lo Schiavo A; Brunetti G; Puca RV; Sangiuliano S; Ruocco E
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):70-1. PubMed ID: 18384563
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
    Andres P; Poncet M; Farzaneh S; Soto P
    J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent.
    Tobin AM; Barragry J; Kirby B; O'Shea L
    Ir Med J; 2005 Apr; 98(4):118. PubMed ID: 15938560
    [No Abstract]   [Full Text] [Related]  

  • 11. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediacy is both a liability and an asset of the Internet.
    Huntley A
    Dermatol Online J; 1997 Dec; 3(2):11b. PubMed ID: 10217739
    [No Abstract]   [Full Text] [Related]  

  • 15. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
    Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
    J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobetasol propionate (Clobex) spray for psoriasis.
    Med Lett Drugs Ther; 2006 Mar; 48(1231):27-8. PubMed ID: 16554700
    [No Abstract]   [Full Text] [Related]  

  • 17. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
    Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
    J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis to Trimovate.
    Corbett JR
    Contact Dermatitis; 1985 Oct; 13(4):281. PubMed ID: 4085236
    [No Abstract]   [Full Text] [Related]  

  • 19. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial.
    Conrotto D; Carbone M; Carrozzo M; Arduino P; Broccoletti R; Pentenero M; Gandolfo S
    Br J Dermatol; 2006 Jan; 154(1):139-45. PubMed ID: 16403107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial vasculitic rash associated with intravenous immunoglobulin.
    Howse M; Bindoff L; Carmichael A
    BMJ; 1998 Nov; 317(7168):1291. PubMed ID: 9804718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.